Primecap Management CO AXOVANT GENE THERAPIES LTD Transaction History

Primecap Management CO

  • $134 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
N/A
-53,225 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
N/A
-1,900 Reduced 3.45%
53,225 $246,000
Q2 2020

Aug 13, 2020
SELL
N/A
-18,700 Reduced 25.33%
55,125 $155,000
Q1 2020

May 14, 2020
SELL
N/A
-46,600 Reduced 38.7%
73,825 $180,000
Q4 2019

Feb 14, 2020
SELL
N/A
-2,862 Reduced 2.32%
120,425 $617,000
Q3 2019

Nov 13, 2019
SELL
N/A
-1,000 Reduced 0.8%
123,287 $796,000
Q2 2019

Aug 14, 2019
BUY
N/A
124,287 New
124,287 $774,000
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email